Venous thromboembolism is the third leading cardiovascular disease in Germany after heart attack and stroke. Anticoagulation is the most important therapeutic measure for acute deep vein thrombosis. She can decide about life and death.
Cardiovascular disease leading to death
According to health experts, the number of thromboses and associated complications of pulmonary embolism has increased significantly in recent years. An undiscovered thrombosis quickly becomes a mortal danger. Venous thromboembolism is the third most common leading to death cardiovascular disease in Germany after heart attack and stroke. In a thrombosis, it is important to act quickly. The right therapy can decide about life and death.
Blood clot clogged Vessel
A thrombus forms a blood clot( thrombus) that can narrow or block a vessel completely. Most commonly, this happens in the leg veins.
When the blood clot is released and flushed into the lungs with the bloodstream, it can block blood vessels( thromboembolism) and cause pulmonary embolism, which is often fatal.
In addition, blood clots can cause a heart attack or stroke and other circulatory disorders.
In Germany alone, around 100,000 people die each year as a result of venous thrombosis and pulmonary embolism.
High age as the main risk factor
While it can generally strike young and old, age is the main risk factor for thrombosis. According to health experts, the danger increases significantly from the age of 60 years.
Even people with varicose veins, lung or heart disease, as well as smokers and obese people have an increased risk of thrombosis.
In addition, it is known that a lack of exercise, such as prolonged bed rest after surgery or while traveling by air and hormonal changes such as in pregnancy have an increased risk of thrombosis.
experts also say that modern anti-baby pills pose a major threat.
Anticoagulation is the most important therapeutic measure
Anticoagulation is the most important therapeutic measure in the case of acute deep vein thrombosis or its possible complication, pulmonary embolism.
The importance of adequate anticoagulation in the treatment of venous thromboembolism( VTE) is illustrated by the following figures:
When anticoagulation is terminated after pulmonary embolism, 25-33 percent of relapses( recurrence) are fatal, reports the German Society for Angiology- Society for Vascular Medicine eV in a message published by the "Informationsdienst Wissenschaft"( idw).
The current interdisciplinary guidelines recommend an individualized decision on the duration of anticoagulation, taking into account patient preferences and clinically important factors.
This deliberately intended flexibility and individualization, however, brings with it a degree of uncertainty for physicians and patients.
The action alliance Thrombose will present the "anticoagulation traffic light" at the world thrombosis day on 13 October under the patronage of Federal Minister of Health Hermann Gröhe in Berlin. This should help treating doctors in the therapy.
will also be discussing vascular experts, general practitioners and other healthcare professionals "on how to further improve intersectoral delivery in venous thromboembolism," states a statement.(ad)